Merck announced today that it will pay $4.85 billion to settle thousands of lawsuits by people who contend they or their family members suffered injury or died after taking Vioxx.
Merck withdrew Vioxx from the market in September 2004, after a clinical trial proved that it increased the risks of heart attacks and strokes. But internal company documents showed that Merck’s scientists were concerned about the risks of Vioxx several years earlier.
Important Vioxx lawsuit news and details on the Vioxx recall. North Carolina lawyers represent Vioxx users who have suffered heart attacks and strokes.
Vioxx has been linked to increased risk of heart attack, stroke, sudden cardiac death and more.
Vioxx is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is also related to the nonselective NSAIDs.